These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 28845591)

  • 41. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.
    Fermoselle C; García-Arumí E; Puig-Vilanova E; Andreu AL; Urtreger AJ; de Kier Joffé ED; Tejedor A; Puente-Maestu L; Barreiro E
    Exp Physiol; 2013 Sep; 98(9):1349-65. PubMed ID: 23625954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.
    Sun R; Zhang S; Lu X; Hu W; Lou N; Zhao Y; Zhou J; Zhang X; Yang H
    Oncol Rep; 2016 Dec; 36(6):3291-3302. PubMed ID: 27748895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PGAM5 interacts with and maintains BNIP3 to license cancer-associated muscle wasting.
    Zhang Q; Chen C; Ma Y; Yan X; Lai N; Wang H; Gao B; Gu AM; Han Q; Zhang Q; La L; Sun X
    Autophagy; 2024 Oct; 20(10):2205-2220. PubMed ID: 38919131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
    Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscle wasting in cancer.
    Johns N; Stephens NA; Fearon KC
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
    AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
    Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
    Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
    Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.
    Martin A; Castells J; Allibert V; Emerit A; Zolotoff C; Cardot-Ruffino V; Gallot YS; Vernus B; Chauvet V; Bartholin L; Schaeffer L; Durieux AC; Hourdé C; Favier FB; Mazelin L; Freyssenet D
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1686-1703. PubMed ID: 35277933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LP07 and LLC preclinical models of lung cancer induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting.
    Belcher DJ; Guitart M; Hain B; Kim HG; Waning D; Barreiro E; Nader GA
    J Appl Physiol (1985); 2022 Dec; 133(6):1260-1272. PubMed ID: 36201324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial fusion and altered beta-oxidation drive muscle wasting in a Drosophila cachexia model.
    Dark C; Ali N; Golenkina S; Dhyani V; Blazev R; Parker BL; Murphy KT; Lynch GS; Senapati T; Millard SS; Judge SM; Judge AR; Giri L; Russell SM; Cheng LY
    EMBO Rep; 2024 Apr; 25(4):1835-1858. PubMed ID: 38429578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
    Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
    Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway.
    Wijaya YT; Setiawan T; Sari IN; Park K; Lee CH; Cho KW; Lee YK; Lim JY; Yoon JK; Lee SH; Kwon HY
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3149-3162. PubMed ID: 36127129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Females display relatively preserved muscle quality compared with males during the onset and early stages of C26-induced cancer cachexia.
    Cabrera AR; Deaver JW; Lim S; Morena da Silva F; Schrems ER; Saling LW; Tsitkanou S; Rosa-Caldwell ME; Wiggs MP; Washington TA; Greene NP
    J Appl Physiol (1985); 2023 Sep; 135(3):655-672. PubMed ID: 37535708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.
    Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N
    Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
    Conte E; Camerino GM; Mele A; De Bellis M; Pierno S; Rana F; Fonzino A; Caloiero R; Rizzi L; Bresciani E; Ben Haj Salah K; Fehrentz JA; Martinez J; Giustino A; Mariggiò MA; Coluccia M; Tricarico D; Lograno MD; De Luca A; Torsello A; Conte D; Liantonio A
    J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):386-404. PubMed ID: 28294567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined Exercise Training Positively Affects Muscle Wasting in Tumor-Bearing Mice.
    Ranjbar K; Ballarò R; Bover Q; Pin F; Beltrà M; Penna F; Costelli P
    Med Sci Sports Exerc; 2019 Jul; 51(7):1387-1395. PubMed ID: 30724848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.